Analyse the association between adverse events (AEs) and survival in patients treated with immune checkpoint inhibitors (ICIs)

被引：0
|
作者：
Cheng, C-Y. [1 ]
Su, P-J. [2 ]
Chang, K-C. [3 ]
Tsai, T-C. [3 ]
Chen, H-Y. [3 ]
Deng, S-T. [3 ]
Chang, W-C. [2 ]
机构：
[1] Linkou Chang Gung Mem Hosp, Chang Gung Med Fdn, Pharm, Taoyuan, Taiwan
[2] Chang Gung Mem Hosp, Med Oncol, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Pharm, Taoyuan, Taiwan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
332P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Association between immune-related adverse events and efficacy of immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma
    Wong, L.
    Ang, A.
    Ng, K.
    Tan, S. H.
    Choo, S. P.
    Tai, D.
    Lee, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [32] Multiomic analysis of immune-related adverse events (irAEs) in melanoma patients treated with anti-PD1-based immune checkpoint inhibitors (ICIs)
    Dimitriou, F.
    Cheng, P.
    Saltari, A.
    Staeger, R.
    Tastanova, A.
    Levesque, M.
    Long, G.
    Becher, B.
    Dummer, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S275 - S275
  • [33] Early incidence of immune-related adverse events (irAEs) predicts efficacy in patients (pts) with solid tumors treated with immune-checkpoint inhibitors (ICIs).
    Morehouse, Chris
    Abdullah, Shaad Essa
    Gao, Chen
    Dar, Mohammed M.
    Ranade, Koustubh
    Higgs, Brandon W.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] Adverse Events of Immune Checkpoint Inhibitors
    Foller, S.
    Oppel-Heuchel, H.
    Fetter, I.
    Winkler, Y.
    Grimm, M. -O.
    UROLOGE, 2017, 56 (04): : 486 - 491
  • [35] Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors
    Gault, A.
    Anderson, A. E.
    Plummer, R.
    Stewart, C.
    Pratt, A. G.
    Rajan, N.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (02) : 263 - 271
  • [36] Sarcopenia and the risk of adverse events in patients treated with immune checkpoint inhibitors: a systematic review
    Guzman-Prado, Yuli
    Ben Shimol, Jennifer
    Samson, Ondrej
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (10) : 2771 - 2780
  • [37] Sarcopenia and the risk of adverse events in patients treated with immune checkpoint inhibitors: a systematic review
    Yuli Guzman-Prado
    Jennifer Ben Shimol
    Ondrej Samson
    Cancer Immunology, Immunotherapy, 2021, 70 : 2771 - 2780
  • [38] Rheumatic immune related adverse events in patients treated with checkpoint inhibitors for immunotherapy of cancer
    Sebastiani, Gian Domenico
    Scirocco, Chiara
    Galeazzi, Mauro
    AUTOIMMUNITY REVIEWS, 2019, 18 (08) : 805 - 813
  • [39] Correlation between immune-related adverse events (irAEs) and efficacy in patients with solid tumors treated with immune-checkpoints inhibitors (ICIs).
    Riudavets, Mariona
    Barba, Andres
    Maroto, Pablo
    Sullivan, Ivana Gabriela
    Anguera, Georgia
    Paez, David
    del Carpio, Luis
    Callejo, Ana
    Gonzalez Blanco, Cintia
    Garcia Planellas, Esther
    Castillo, Diego
    Facundo, Carme
    Genua, Idoia
    Martin Lorente, Cristina
    Virgili, Ana
    Sebio, Ana
    Gallego, Oscar
    Lopez-Pousa, Antonio
    Barnadas, Agust
    Majem, Margarita
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] Analysis of immune-related adverse events in gastrointestinal malignancy patients treated with immune checkpoint inhibitors
    Niu, Chengu
    Zhu, Kaiwen
    Zhang, Jing
    Joshi, Utsav
    Liu, Hongli
    Zahid, Salman
    Jadhav, Nagesh
    Okolo, Patrick I.
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (07) : 1261 - 1271
12345